GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
28.12
+0.14 (0.50%)
Jul 30, 2026, 1:08 PM EDT - Market open
GH Research Market Cap
GH Research has a market cap or net worth of $1.93 billion as of July 30, 2026. Its market cap has increased by 107.77% in one year.
Market Cap
1.93B
Enterprise Value
1.67B
1-Year Change
107.77%
Ranking
Category
Stock Price
$28.12
ChartMarket Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has increased from $808.33M to $1.93B, an increase of 138.67%. That is a compound annual growth rate of 18.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2026 | 1.93B | 144.90% |
| Dec 31, 2025 | 787.77M | 116.30% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
| Jun 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biohaven | 2.00B |
| Zenas BioPharma | 2.00B |
| UroGen Pharma | 1.99B |
| Precigen | 1.99B |
| ADMA Biologics | 1.98B |
| Aurinia Pharmaceuticals | 1.92B |
| Fortrea Holdings | 1.91B |
| Nanobiotix | 1.90B |